A newly defined threshold for the concentration of the cytokine CXCL13 may improve the diagnosis of neuroborreliosis.
Optimind Pharma Closes First Tranche of Private Placement | Psychedelic Invest
Toronto, Ontario–(Newsfile Corp. – July 8, 2024) – Optimind Pharma Corp. (CSE: OMND) (“Optimind” or the “Company”) announces it has closed the first trance of
July 9, 2024